Labcorp Holdings
$308.49Change from previous close: +1.28%Absolute change: +$3.89
At a glance
- Revenue growth
- +7.25%
- 2025 vs 2024
- Net income growth
- +17.49%
- 2025 vs 2024
- Net margin
- 6.3%
- 2024: 5.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 3,731 | 3,538 | 3,516 | 3,564 | 3,527 | — |
| Cost of revenue | 2,619 | 2,524 | 2,523 | 2,538 | 2,481 | — |
| Gross profit | 1,112 | 1,014 | 993 | 1,025 | 1,046 | — |
| Selling, general and administrative | 577 | 551 | 539 | 552 | 579 | — |
| Operating income | 457 | 387 | 382 | 403 | 399 | — |
| EBIT | 448 | 375 | 246 | 393 | 362 | — |
| EBITDA | 627 | 548 | 419 | 564 | 532 | — |
| Interest expense | 61.1 | 55.1 | 55.0 | 56.0 | 57.1 | — |
| Pre-tax income | 386 | 320 | 191 | 337 | 305 | — |
| Income tax | 87.3 | 41.7 | 25.7 | 75.5 | 66.4 | — |
| Net income | 299 | 278 | 165 | 261 | 238 | — |
| Net income to common shareholders | 299 | 278 | 165 | 261 | 238 | — |
| Basic EPS | 3.66 | 3.37 | 2.00 | 3.14 | 2.85 | — |
| Diluted EPS | 3.64 | 3.35 | 1.98 | 3.12 | 2.84 | — |
| Average shares (basic) | 81.7 | 82.3 | 82.5 | 83.1 | 83.4 | — |
| Average shares (diluted) | 82.0 | 82.9 | 83.2 | 83.7 | 83.9 | — |